SOLIGENIX, INC. — Director's Dealing 2022

Jan 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-01-21

Reporting Person: Guarino Jonathan L. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-21	Option (Right to Buy)	$0.78	A	50000	Acquired	2031-12-08	Common Stock (50000)	Direct

Footnotes

F1: The terms of the stock option provide that it is to vest immediately as to 12,500 shares and to vest as to the remainder at a rate of 3,125 of the shares every three months, beginning on March 12, 2022; provided, however, that, consistent with the 2015 Equity Incentive Plan (the "Plan") and the rules of the Nasdaq Stock Market, such stock option shall not be exercisable nor shall it vest prior to the time when an amendment increasing the number of shares authorized for issuance under the Plan is approved by the stockholders, and provided further that, if such approval has not been obtained within 12 months of the grant date, the stock option shall thereupon be canceled and become null and void. The reporting person voluntarily agreed to cancel the stock option granted December 9, 2021 with respect to 50,000 shares.